208 related articles for article (PubMed ID: 5743942)
1. [Lipacidemia and glycemia variations during intravenous tolbutamide test of 126 normal and diabetic persons].
Deuil R; Deloux G; Duval JM; Davy J; Guinard UJ; Letailleur M
Diabete; 1968; 16(1):45-53. PubMed ID: 5743942
[No Abstract] [Full Text] [Related]
2. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
Torri A; Zandomeneghi R; Sgarbi E
Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
[No Abstract] [Full Text] [Related]
3. [Asymptomatic diabetes mellitus in normal weight subjects with hypertension. Studies on glucose tolerance, serum insulin and nonesterified fatty acids in essential hypertension].
Dieterle P; Fehm H; Ströder W; Henner J; Bottermann P; Schwarz K
Dtsch Med Wochenschr; 1967 Dec; 92(52):2376-81. PubMed ID: 6073582
[No Abstract] [Full Text] [Related]
4. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
Locatelli GR; Piotti LE
G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
[No Abstract] [Full Text] [Related]
5. [Intravenous tolbutamide test in the diagnosis of diabetes. Critical review and case studies].
Fuà C; Mazzi F; Peracino
Clin Ter; 1972 Feb; 60(3):229-43. PubMed ID: 4579709
[No Abstract] [Full Text] [Related]
6. Asymptomatic diabetes mellitus in hypertensive patients of normal weight. Glucose tolerance and serum levels of insulin and nonesterified fatty acids in essential hypertension.
Dieterle P; Fehm H; Ströder W; Henner J; Bottermann P; Schwarz K
Ger Med Mon; 1968 Oct; 13(10):478-83. PubMed ID: 5707015
[No Abstract] [Full Text] [Related]
7. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
[No Abstract] [Full Text] [Related]
8. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
Zandomeneghi R
Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
[No Abstract] [Full Text] [Related]
9. [Unlimited usefulness of the intravenous tolbutamide test in the early diagnosis of over 45-year-old diabetics].
Schneider H; Wache HW
Z Gesamte Inn Med; 1970 Dec; 25(24):1133-5. PubMed ID: 5520027
[No Abstract] [Full Text] [Related]
10. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
Ulrich E; Frank I; Kujat G; Müller G; Seige K
Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
[No Abstract] [Full Text] [Related]
11. Studies in subjects with positive postprandial Clinistix test. 3. Special studies and follow-up of cases with borderline glucose tolerance.
Carlström S; Lundquist A; Lundquist I; Nordén A; Scherstén B; Wollmark G
Acta Med Scand; 1971 May; 189(5):415-22. PubMed ID: 5578492
[No Abstract] [Full Text] [Related]
12. [Criteria for the differentiation of free fatty acid behavior in the serum during tolbutamide test in health persons and latent diabetes].
Lange HJ; Knick B; Stix H
Verh Dtsch Ges Inn Med; 1968; 74():932-4. PubMed ID: 5714451
[No Abstract] [Full Text] [Related]
13. [Early diagnosis of diabetic disease].
Sensi S
Minerva Med; 1973 Sep; 64(62):3219-49. PubMed ID: 4775165
[No Abstract] [Full Text] [Related]
14. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
Kirti S; Dutta PK; Vaishnava H; Singh RB
J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
[No Abstract] [Full Text] [Related]
15. [Use of the tolbutamide test in the differential diagnosis of a latent disorder of carbohydrate metabolism].
Jedlicková J
Vnitr Lek; 1968 Sep; 14(9):871-7. PubMed ID: 5680886
[No Abstract] [Full Text] [Related]
16. [Variations of insulinemia and glycemia compared in the course of an intravenous tolbutamide test in 29 persons].
Vague J; Depieds R; Codaccioni JL; Vague P; Boeuf G
Bull Mem Soc Med Hop Paris; 1965 Oct; 116(13):Suppl:1367-81. PubMed ID: 5859607
[No Abstract] [Full Text] [Related]
17. [Effects of the tolbutamide test on plasmatic concentration of NEFA in the climacteric].
Quinto P; Orlandi C
Minerva Ginecol; 1968 Apr; 20(8):678-87. PubMed ID: 5738756
[No Abstract] [Full Text] [Related]
18. [On the use of the tolbutamide test in pancreatic carcinoma].
Thimm R
Z Arztl Fortbild (Jena); 1967 Jun; 61(11):573-4. PubMed ID: 5591880
[No Abstract] [Full Text] [Related]
19. [Role of plasma free fatty acid (FFA) levels during oral glucose tolerance and tolbutamide tolerance tests and the FFA rebound index in the detection of prediabetes and latent diabetes].
Bagriaçik N
Diabete; 1970; 18(4):253-61. PubMed ID: 5501962
[No Abstract] [Full Text] [Related]
20. [Intravenous glucose and tolbutamide tolerance test. Methodical and comparative studies].
Eggstein M; Henning R; Knodel W
Med Welt; 1969 Jan; 1():1-6. PubMed ID: 5775504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
